Liza Dunne is an experienced company director and executive specialising in medical device development and commercialisation. In October 2016, she was appointed the inaugural chief executive of Perth-based OncoRes Medical. She previously spent 11 years at ASX-listed Resonance Health, including six years as managing director up to her resignation in January 2015. Prior to that, Ms Dunne was a senior project manager with KPMG Consulting and in the early part of her career, she held product management and finance positions within IBM.